180 related articles for article (PubMed ID: 38064656)
1. Adolescents and Young Adults With Cancer: CNS Tumors.
Wu J; Heidelberg RE; Gajjar A
J Clin Oncol; 2024 Feb; 42(6):686-695. PubMed ID: 38064656
[TBL] [Abstract][Full Text] [Related]
2. Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor Types.
Wagner MW; Jabehdar Maralani P; Bennett J; Nobre L; Lim-Fat MJ; Dirks P; Laughlin S; Tabori U; Ramaswamy V; Hawkins C; Ertl-Wagner BB
Radiology; 2024 Feb; 310(2):e230777. PubMed ID: 38349246
[TBL] [Abstract][Full Text] [Related]
3. Brain Tumors in Adolescents and Young Adults: A Review.
Rousseau J; Bennett J; Lim-Fat MJ
Semin Neurol; 2023 Dec; 43(6):909-928. PubMed ID: 37949116
[TBL] [Abstract][Full Text] [Related]
4. Treatment and Outcomes for Central Nervous System Tumors in Australian Adolescents and Young Adults: A Population-Based National Study.
Harrup R; White VM; Coory M; Walker R; Anazodo A; Skaczkowski G; Bibby H; Osborn M; Phillips MB; Conyers R; Thompson K; Orme LM; Pinkerton R; Nicholls W
J Adolesc Young Adult Oncol; 2021 Apr; 10(2):202-208. PubMed ID: 32856982
[No Abstract] [Full Text] [Related]
5. Advances in the biology and treatment of pediatric central nervous system tumors.
Vitanza NA; Cho YJ
Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
[TBL] [Abstract][Full Text] [Related]
6. The unique immune ecosystems in pediatric brain tumors: integrating single-cell and bulk RNA-sequencing.
Cao L; Xie W; Ma W; Zhao H; Wang J; Liang Z; Tian S; Wang B; Ma J
Front Immunol; 2023; 14():1238684. PubMed ID: 38094301
[TBL] [Abstract][Full Text] [Related]
7. Clinical Trial Enrollment Among Adolescent and Young Adults with Primary Central Nervous System Tumors Treated at the Dana-Farber Cancer Institute.
Sarvode S; Vogelzang JR; Sarvode Mothi S; Warren KE; Reardon DA; Yeo KK
J Adolesc Young Adult Oncol; 2022 Dec; 11(6):543-549. PubMed ID: 35049364
[No Abstract] [Full Text] [Related]
8. Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
Leary SES; Onar-Thomas A; Fangusaro J; Gottardo NG; Cohen K; Smith A; Huang A; Haas-Kogan D; Fouladi M;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30600. PubMed ID: 37534382
[TBL] [Abstract][Full Text] [Related]
9. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
Cacciotti C; Fleming A; Ramaswamy V
J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
[TBL] [Abstract][Full Text] [Related]
10. Review of the genomic landscape of common pediatric CNS tumors and how data sharing will continue to shape this landscape in the future.
Kaneva K; Goldman S
Mol Biol Rep; 2021 Nov; 48(11):7537-7544. PubMed ID: 34643931
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Neuro-Oncology.
Malbari F
Neurol Clin; 2021 Aug; 39(3):829-845. PubMed ID: 34215389
[TBL] [Abstract][Full Text] [Related]
13. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
Robinson GW; Witt H; Resnick A
Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
[TBL] [Abstract][Full Text] [Related]
14. Pediatric CNS tumors: current treatment and future directions.
Hargrave DR; Zacharoulis S
Expert Rev Neurother; 2007 Aug; 7(8):1029-42. PubMed ID: 17678498
[TBL] [Abstract][Full Text] [Related]
15. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
Plant-Fox AS; O'Halloran K; Goldman S
Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
[TBL] [Abstract][Full Text] [Related]
16. Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.
Juratli TA; Jungk C; Miller JJ
J Neurooncol; 2023 May; 162(3):457-459. PubMed ID: 37212938
[No Abstract] [Full Text] [Related]
17. CNS Tumors in Adolescents and Young Adults: The Need for a Holistic Specialized Approach.
Papageorgiou GI; Razis ED
JCO Oncol Pract; 2020 Apr; 16(4):155-162. PubMed ID: 32048937
[TBL] [Abstract][Full Text] [Related]
18. Current practice of cancer predisposition testing in pediatric patients with CNS tumors in the United States.
Roy B; Knapke S; Pillay-Smiley N; Zhang X; Queen K; Sisson R
Pediatr Blood Cancer; 2024 Jan; 71(1):e30725. PubMed ID: 37859593
[TBL] [Abstract][Full Text] [Related]
19. Distinct demographic profile and molecular markers of primary CNS tumor in 1873 adolescent and young adult patient population.
Vadgaonkar R; Epari S; Chinnaswamy G; Krishnatry R; Tonse R; Gupta T; Jalali R
Childs Nerv Syst; 2018 Aug; 34(8):1489-1495. PubMed ID: 29730791
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas.
Lazow MA; Salloum R; Pressey JG
J Adolesc Young Adult Oncol; 2023 Apr; 12(2):215-223. PubMed ID: 35675692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
